Pharma Business - October 19, 2015
Restructuring at Recipharm
Recipharm announces cost and efficiency program in Sweden. In the Swedish part of the Business Segment Solids and Others, Recipharm sees a need to adapt to lower actual and forecasted volumes of certain products and capture opportunities for improved efficiency. Therefore, accelerated cost and efficiency activities will start during Q4 2015 and run through 2016. These activities will affect […]
Agreement - September 1, 2015
Recipharm in agreement with LobSor Pharmaceuticals
The Swedish CDMO Recipharm reaches agreement with LobSor Pharmaceuticals to manufacture LECIGONTM, a proprietary treatment for advanced Parkinson’s disease. Recipharm and LobSor Pharmaceuticals, an Uppsala-based pharmaceutical company focusing on the development of innovative systems to treat symptoms of advanced Parkinson’s disease (APD), has agreed on a manufacturing agreement for LECIGON. As part of the agreement, […]
Acquisition - August 26, 2015
Recipharm signs agreement with RedHill Biopharma
Recipharm has announces that it has signed an agreement with Israeli biopharmaceutical company RedHill Biopharma for the manufacturing of RedHill’s leading, late-stage patented drug candidate, RHB-105. RHB-105 is being developed for the treatment of Helicobacter pylori (H. pylori) bacterial infection, a global market estimated at about $4.8 billion. Recipharm will be responsible for the supply […]
In a new job - July 1, 2015
Recipharm Names Sales Director for France
Recipharm has appointed Amine Tahiri as its new sales director for France.Tahiri has more than 16 years experience working in the pharmaceuticals industry, and most recently was commercial manager at Recipharm Fontaine S.A.S. Torkel Gren, Recipharm’s senior sales director, development services at Recipharm, says, “I am very happy to welcome such a talent in the […]
In a new job - June 2, 2015
Recipharm Taps Chief Strategy Officer
Jean-François Hilaire was named to the new position of chief strategy officer for Recipharm on Monday, according to the company. Hilaire began work Monday and will join the Group’s Executive Committee. “Jean-François Hilaire brings valuable and relevant experience in the pharmaceutical industry in general, and also has important insights from the outsourcing of drug development […]
Collaboration - May 11, 2015
Recipharm, LIDDS Talk Collaboration
Recipharm has begun negotiations with the pharmaceutical company LIDDS about collaborating on making Liproca Depot® ahead of continued clinical development and a potential future market launch. The companies explained in a joint letter their intention to initiate collaboration in the areas of scale-up, manufacture and quality assurance of LIDDS’ pharmaceutical products. Initially the companies will […]
